Depression and type 2 diabetes: Cortisol pathway implication and investigational needs

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2318-2322

  Gragnoli, Claudia ^a,b,c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b Bios Biotech Multi Diagnostic Health Center   (Italy)

^c Temple University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; FATTY ACID; GLUCOSE; HYDROCORTISONE;

ANXIETY; ATYPICAL DEPRESSION; CIRCADIAN RHYTHM; CORTICOTROPIN RELEASE; DEPRESSION; DIABETOGENESIS; DISEASE ASSOCIATION; FATTY ACID SYNTHESIS; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RESISTANCE; LIMBIC SYSTEM; LIPOLYSIS; LIPOTOXICITY; MAJOR DEPRESSION; MELANCHOLIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; REVIEW; STRESS;

ANIMALS; ANXIETY; DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; UP-REGULATION;

EID: 84857475708     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23012     Document Type: Review

References (44)

1. Aguilera G. 1994. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15: 321-350.
2. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders (Revised 4th ed.). Washington, DC: Author.
3. Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF. 2000. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410-414.
4. Buse J, Polonsky K, Burant C. 2008. Type 2 diabetes mellitus. Williams textbook of endocrinology, Chapter 30, 11th edition. USA: Saunders/Elesevier.
5. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. 1996. Corticotrophin-releasing factor receptors: From molecular biology to drug design. Trends Pharmacol Sci 17: 166-172.
6. Chen R, Lewis KA, Perrin MH, Vale WW. 1993. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90: 8967-8971.
7. Chrousos GP, Gold PW. 1992. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267: 1244-1252.
8. Chrousos GP, Gold PW. 1998. A healthy body in a healthy mind-And vice versa-The damaging power of "uncontrollable" stress. J Clin Endocrinol Metab 83: 1842-1845.
9. Chrousos GP, Loriaux DL, Gold PW. 1988. Mechanisms of physical and emotional stress. Adv Exp Med Biol 245.
10. Coderre L, Vallega GA, Pilch PF, Chipkin SR. 1996. In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol 271: E643-E648.
11. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP. 2000. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24: 403-409.
12. Cummings S, Elde R, Ells J, Lindall A. 1983. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: An immunohistochemical study. J Neurosci 3: 1355-1368.
13. Desir D, Van Cauter E, Fang VS, Martino E, Jadot C, Spire JP, Noel P, Refetoff S, Copinschi G, Golstein J. 1981. Effects of "jet lag" on hormonal patterns. I. Procedures, variations in total plasma proteins, and disruption of adrenocorticotropin-cortisol periodicity. J Clin Endocrinol Metab 52: 628-641.
14. Garvey WT, Huecksteadt TP, Monzon R, Marshall S. 1989. Dexamethasone regulates the glucose transport system in primary cultured adipocytes: Different mechanisms of insulin resistance after acute and chronic exposure. Endocrinology 124: 2063-2073.
15. Gold PW, Chrousos GP. 2002. Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs. low CRH/NE states. Mol Psychiatry 7: 254-275.
16. Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL. 1984. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141: 619-627.
17. Gold PW, Goodwin FK, Chrousos GP. 1988. Clinical and biochemical manisfestations of depression: Relation to the neurobiology of stress (Part 2 of 2 parts). N Engl J Med 319: 348-353.
18. Gold PW, Goodwin FK, Chrousos GP. 1988. Clinical and biochemical manisfestations of depression: Relation to the neurobiology of stress (Part 1 of 2 parts). N Engl J Med 319: 413-420.
19. Herman JP, Cullinan WE. 1997. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20: 78-84.
20. Herman JP, Figueiredo H, Mueller NK, Ulrich-Lai Y, Ostrander MM, Choi DC, Cullinan WE. 2003. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front Neuroendocrinol 24: 151-180.
21. Herman JP, Ostrander MM, Mueller NK, Figueiredo H. 2005. Limbic system mechanisms of stress regulation: Hypothalamo-pituitary-adrenocortical axis. Prog Neuropsychopharmacol Biol Psychiatry 29: 1201-1213.
22. Horwath E, Johnson J, Weissman MM, Hornig CD. 1992. The validity of major depression with atypical features based on a community study. J Affect Disord 26: 117-125.
23. Huising MO, van der Meulen T, Vaughan JM, Matsumoto M, Donaldson CJ, Park H, Billestrup N, Vale WW. 2010. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc Natl Acad Sci USA 107: 912-917.
24. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. 1993. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21: 618-623.
25. Kyrou I, Tsigos C. 2009. Stress hormones: Physiological stress and regulation of metabolism. Curr Opin Pharmacol 9: 787-793.
26. Lambillotte C, Gilon P, Henquin JC. 1997. Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest 99: 414-423.
27. Liaw CW, Lovenberg TW, Barry G, Oltersdorf T, Grigoriadis DE, de Souza EB. 1996. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology 137: 72-77.
28. Liaw CW, Grigoriadis DE, Lovenberg TW, De Souza EB, Maki RA. 1997. Localization of ligand-binding domains of human corticotropin-releasing factor receptor: A chimeric receptor approach. Mol Endocrinol 11: 980-985.
29. Melmed S, Jameson JL, 2011. Disorders of the anterior pituitary and hypothalamus Harrison's principles of internal medicine chapter 333. New York: McGraw-Hill Medical Publishing Division. 17e.
30. Mezuk B, Eaton WW, Albrecht S, Golden SH. 2008. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care 31: 2383-2390.
31. Millan MA, Samra AB, Wynn PC, Catt KJ, Aguilera G. 1987. Receptors and actions of corticotropin-releasing hormone in the primate pituitary gland. J Clin Endocrinol Metab 64: 1036-1041.
32. Muller MB, Preil J, Renner U, Zimmermann S, Kresse AE, Stalla GK, Keck ME, Holsboer F, Wurst W. 2001. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: Implications for HPA system regulation. Endocrinology 142: 4150-4153.
33. Muller MB, Zimmermann S, Sillaber I, Hagemeyer TP, Deussing JM, Timpl P, Kormann MS, Droste SK, Kuhn R, Reul JM, Holsboer F, Wurst W. 2003. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci 6: 1100-1107.
34. Obunai K, Jani S, Dangas GD. 2007. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 91: 1169-1184 x.
35. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM, Imbimbo B. 1983. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72: 1814-1820.
36. Preil J, Muller MB, Gesing A, Reul JM, Sillaber I, van Gaalen MM, Landgrebe J, Holsboer F, Stenzel-Poore M, Wurst W. 2001. Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2. Endocrinology 142: 4946-4955.
37. Rosolova H, Podlipny J. 2009. Anxious-depressive disorders and metabolic syndrome. Vnitr Lek 55: 650-652.
38. Stewart P. 2008. The adrenal cortex. Williams textbook of endocrinology, Chapter 14, 11th edition. USA: Saunders/Elesevier.
39. Swanson LW, Sawchenko PE, Rivier J, Vale WW. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology 36: 165-186.
40. Tayek JA, Katz J. 1997. Glucose production, recycling, Cori cycle, and gluconeogenesis in humans: Relationship to serum cortisol. Am J Physiol 272: E476-E484.
41. Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. 2002. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 64: 418-435.
42. Wajngot A, Khan A, Giacca A, Vranic M, Efendic S. 1990. Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects. Am J Physiol 259: E626-E632.
43. Watanabe T, Orth DN. 1987. Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: Effects of ovine corticotropin-releasing factor and arginine vasopressin. Endocrinology 121: 1133-1145.
44. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD, Jr., DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW. 2000. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97: 325-330.